{
    "2021-08-31": [
        [
            {
                "time": "",
                "original_text": "逾700家上市公司上半年炒493只A股：哪些亏损，哪些赚钱？",
                "features": {
                    "keywords": [
                        "上市公司",
                        "炒股",
                        "亏损",
                        "赚钱"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "北向资金连续7日净买入8月累计加仓270亿，中国平安逆势遭抛售超20亿",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "加仓",
                        "中国平安",
                        "抛售"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "调研记录|云南白药（000538.SZ）：云南白药“采之汲”APP重磅上线 “白药植提牌三七总皂苷”销售额有望单品破亿",
                "features": {
                    "keywords": [
                        "云南白药",
                        "采之汲",
                        "APP",
                        "三七总皂苷",
                        "销售额"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "云南白药(000538)：剔除激励费用业绩增长理想 战略转型值得期待",
                "features": {
                    "keywords": [
                        "云南白药",
                        "激励费用",
                        "业绩增长",
                        "战略转型"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}